SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABMD - Replacement Heart System
ABMD 381.020.0%Jan 3 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (42)1/31/2001 8:20:15 AM
From: Mark Johnson   of 147
 
opal: The FDA approved the AbioCor in record time because of the complete and comprehensive data compiled by Abiomed....I don't think there has been a single mechanical failure in the calf tests. The intial patients who will receive the AbioCor are very sick people who face imminent death. As far as liability concerns.... if the heart has problems the shareholders will feel the markets wrath long before any lawsuits are filed.....but if it works and the AbioCor improves the quality of life in these people with end stage heart failure who knows how high this company will fly....

MJ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext